Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivasmental-behavioural-and-psychosomatic

Paeds Vivas · mental-behavioural-and-psychosomatic

Early-onset psychosis and mania — branching viva

Branching viva on the psychosis-mania gate: distinguishing psychosis, mania and mimics, organic exclusion, duration of untreated psychosis, cannabis risk, TEOSS and the paediatric mania trials, and antipsychotic metabolic monitoring.

branching clinical structured oral4 min readVerification in progress

Target exams

RACP DCEMRCPCH Clinical
On this page
Study tools

Target exams

RACP DCEMRCPCH Clinical
Prompt
Clinic: a 15-year-old with new persecutory beliefs, auditory hallucinations, four nights without sleep and daily high-potency cannabis use; the examiner may probe mania, organic mimics, clinical high risk and substance-induced states mid-station.

Opening

Examiner: A 15-year-old boy is brought in believing classmates implanted a chip in his head, has not slept for four nights, and smokes high-potency cannabis daily. Walk me through your approach from the moment you meet him. [2]

Candidate: He is a medical patient first and a psychiatric patient second. I run the gate in order: assess, distinguish, exclude danger, refer early and treat. I greet him first, set a joint agenda, and secure time alone with conditional confidentiality stated aloud. Because a psychotic young person is an unreliable sole historian, I gather collateral from family and school on onset, course, function, family psychiatric history, substance use and trauma. I perform a mental-state examination, run HEEADSSS with focused probes, and screen suicide risk with plan, intent and means — then exclude organic disease before any label. [2]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References9ShowHide
  1. [1]Sikich L, Frazier JA, McClellan J, Findling RL, Vitiello B, et al. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study. American Journal of Psychiatry, 2008.PMID 18794207
  2. [2]McClellan J, Stock S Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 2013.PMID 23972700
  3. [3]Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry, 2008.PMID 18180426
  4. [4]Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry, 2014.PMID 25252316
  5. [5]Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 2007.PMID 17662880
  6. [6]Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ, 2002.PMID 12446537
  7. [7]Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry, 2012.PMID 22213771
  8. [8]Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, et al. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. American Journal of Psychiatry, 2006.PMID 16816222
  9. [9]Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. American Journal of Psychiatry, 2007.PMID 17898346
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousDisruptive mood dysregulation disorder — branching vivamental-behavioural-and-psychosomaticNextEmergency mental-health assessment and disposition — branching vivamental-behavioural-and-psychosomatic